Research Center
At the session held on March 12, 2022. year, the Board of Directors of the private health care institution Special Hospital "PLAVA MEDICAL GROUP" with polyclinic Tuzla, passed Decision No. 2169/22 on the establishment of the Research Center.
The following were appointed as permanent members of the Research Center:
- Prim.dr.Senada Hujdurović, the president
- Dr. Džemal Garagić, mr.sci.med. – Deputy President
- Acc.prof. dr.sci.med. Enver Zerem – member
- Prof.dr.sci.med. Nermina Kravić – member
- Dr. Admir Kurtćehajić, mr.sci.med.. – member
- Dr.Amra Delić, mr.sci.med – member
- Edin Bukvić, dipl.oecc – member
- Meliha Hrustić, dipl.med.sestra – member
- Adisa Goletić-Vejzovič, Bachelor of Laws - member
Clinical studies
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GUSELKUMAB SUBCUTANEOUS INDUCTION THERAPY IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
2022-u toku
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF COBITOLIMOD AS AN INDUCTION AND MAINTENANCE THERAPY IN PARTICIPANTS WITH MODERATE TO SEVERE ACTIVE LEFT-SIDED ULCERATIVE COLITIS
2021-u toku
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GUSELKUMAB SUBCUTANEOUS INDUCTION THERAPY IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
2017-2020
